Polygenic Risk Score Predicts Modified Risk in <i>BRCA1</i> Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients

The aim of this study was to assess the power of the polygenic risk score (PRS) in estimating the overall genetic risk of women carrying germline <i>BRCA1</i> pathogenic variants (PVs) c.4035del or c.5266dup to develop breast (BC) or ovarian cancer (OC) due to additional genetic variatio...

Full description

Bibliographic Details
Main Authors: Egija Berga-Švītiņa, Jeļena Maksimenko, Edvīns Miklaševičs, Krista Fischer, Baiba Vilne, Reedik Mägi
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/11/2957
_version_ 1797597772213387264
author Egija Berga-Švītiņa
Jeļena Maksimenko
Edvīns Miklaševičs
Krista Fischer
Baiba Vilne
Reedik Mägi
author_facet Egija Berga-Švītiņa
Jeļena Maksimenko
Edvīns Miklaševičs
Krista Fischer
Baiba Vilne
Reedik Mägi
author_sort Egija Berga-Švītiņa
collection DOAJ
description The aim of this study was to assess the power of the polygenic risk score (PRS) in estimating the overall genetic risk of women carrying germline <i>BRCA1</i> pathogenic variants (PVs) c.4035del or c.5266dup to develop breast (BC) or ovarian cancer (OC) due to additional genetic variations. In this study, PRSs previously developed from two joint models using summary statistics of age-at-onset (BayesW model) and case–control data (BayesRR-RC model) from a genome-wide association analysis (GWAS) were applied to 406 germline <i>BRCA1</i> PV (c.4035del or c.5266dup) carriers affected by BC or OC, compared with unaffected individuals. A binomial logistic regression model was used to assess the association of PRS with BC or OC development risk. We observed that the best-fitting BayesW PRS model effectively predicted the individual’s BC risk (OR = 1.37; 95% CI = 1.03–1.81, <i>p</i> = 0.02905 with AUC = 0.759). However, none of the applied PRS models was a good predictor of OC risk. The best-fitted PRS model (BayesW) contributed to assessing the risk of developing BC for germline <i>BRCA1</i> PV (c.4035del or c.5266dup) carriers and may facilitate more precise and timely patient stratification and decision-making to improve the current BC treatment or even prevention strategies.
first_indexed 2024-03-11T03:10:10Z
format Article
id doaj.art-0bd521f81ace473dbedab0adb26a9ae2
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T03:10:10Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-0bd521f81ace473dbedab0adb26a9ae22023-11-18T07:38:49ZengMDPI AGCancers2072-66942023-05-011511295710.3390/cancers15112957Polygenic Risk Score Predicts Modified Risk in <i>BRCA1</i> Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer PatientsEgija Berga-Švītiņa0Jeļena Maksimenko1Edvīns Miklaševičs2Krista Fischer3Baiba Vilne4Reedik Mägi5Bioinformatics Lab, Rīga Stradiņš University, Dzirciema Street 16, LV-1007 Riga, LatviaInstitute of Oncology, Rīga Stradiņš University, Pilsoņu Street 13, Block 13, LV-1002 Riga, LatviaInstitute of Oncology, Rīga Stradiņš University, Pilsoņu Street 13, Block 13, LV-1002 Riga, LatviaInstitute of Genomics, University of Tartu, Riia 23b, 51010 Tartu, EstoniaBioinformatics Lab, Rīga Stradiņš University, Dzirciema Street 16, LV-1007 Riga, LatviaInstitute of Genomics, University of Tartu, Riia 23b, 51010 Tartu, EstoniaThe aim of this study was to assess the power of the polygenic risk score (PRS) in estimating the overall genetic risk of women carrying germline <i>BRCA1</i> pathogenic variants (PVs) c.4035del or c.5266dup to develop breast (BC) or ovarian cancer (OC) due to additional genetic variations. In this study, PRSs previously developed from two joint models using summary statistics of age-at-onset (BayesW model) and case–control data (BayesRR-RC model) from a genome-wide association analysis (GWAS) were applied to 406 germline <i>BRCA1</i> PV (c.4035del or c.5266dup) carriers affected by BC or OC, compared with unaffected individuals. A binomial logistic regression model was used to assess the association of PRS with BC or OC development risk. We observed that the best-fitting BayesW PRS model effectively predicted the individual’s BC risk (OR = 1.37; 95% CI = 1.03–1.81, <i>p</i> = 0.02905 with AUC = 0.759). However, none of the applied PRS models was a good predictor of OC risk. The best-fitted PRS model (BayesW) contributed to assessing the risk of developing BC for germline <i>BRCA1</i> PV (c.4035del or c.5266dup) carriers and may facilitate more precise and timely patient stratification and decision-making to improve the current BC treatment or even prevention strategies.https://www.mdpi.com/2072-6694/15/11/2957polygenic risk score (PRS)breast cancerovarian cancer<i>BRCA1</i> pathogenic variant carriers
spellingShingle Egija Berga-Švītiņa
Jeļena Maksimenko
Edvīns Miklaševičs
Krista Fischer
Baiba Vilne
Reedik Mägi
Polygenic Risk Score Predicts Modified Risk in <i>BRCA1</i> Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients
Cancers
polygenic risk score (PRS)
breast cancer
ovarian cancer
<i>BRCA1</i> pathogenic variant carriers
title Polygenic Risk Score Predicts Modified Risk in <i>BRCA1</i> Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients
title_full Polygenic Risk Score Predicts Modified Risk in <i>BRCA1</i> Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients
title_fullStr Polygenic Risk Score Predicts Modified Risk in <i>BRCA1</i> Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients
title_full_unstemmed Polygenic Risk Score Predicts Modified Risk in <i>BRCA1</i> Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients
title_short Polygenic Risk Score Predicts Modified Risk in <i>BRCA1</i> Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients
title_sort polygenic risk score predicts modified risk in i brca1 i pathogenic variant c 4035del and c 5266dup carriers in breast cancer patients
topic polygenic risk score (PRS)
breast cancer
ovarian cancer
<i>BRCA1</i> pathogenic variant carriers
url https://www.mdpi.com/2072-6694/15/11/2957
work_keys_str_mv AT egijabergasvitina polygenicriskscorepredictsmodifiedriskinibrca1ipathogenicvariantc4035delandc5266dupcarriersinbreastcancerpatients
AT jelenamaksimenko polygenicriskscorepredictsmodifiedriskinibrca1ipathogenicvariantc4035delandc5266dupcarriersinbreastcancerpatients
AT edvinsmiklasevics polygenicriskscorepredictsmodifiedriskinibrca1ipathogenicvariantc4035delandc5266dupcarriersinbreastcancerpatients
AT kristafischer polygenicriskscorepredictsmodifiedriskinibrca1ipathogenicvariantc4035delandc5266dupcarriersinbreastcancerpatients
AT baibavilne polygenicriskscorepredictsmodifiedriskinibrca1ipathogenicvariantc4035delandc5266dupcarriersinbreastcancerpatients
AT reedikmagi polygenicriskscorepredictsmodifiedriskinibrca1ipathogenicvariantc4035delandc5266dupcarriersinbreastcancerpatients